rs5569
| SNP: rs5569 | |
|---|---|
| Name(s) | A1287G, G1287A |
| Gene | SLC6A2 |
| Chromosome | 16 |
| Region | Exon 9 |
| External databases | |
| Ensembl | Human SNPView |
| dbSNP | 5569 |
| HapMap | 5569 |
| SNPedia | 5569 |
In genetics, rs5569 (A1287G or G1287A) is a genetic variant. It is a single nucleotide polymorphism (SNP) in the SLC6A2 gene in exon 9. This gene codes the norepinephrine transporter. The SNP is a silent substitution and the nucleotides of both variants code a threonine amino acid.[1]
Several research studies have examined the effect of the variant in relation to alcohol dependence,[2][3] attention deficit hyperactivity disorder,[4] diabetes,[5] major depressive disorder,[6][7] panic disorder,[8] Tourette syndrome[9] and personality traits.[10] None of the studies have found an association.
References
[edit]- ^ dbSNP
- ^ Jerzy Samochowiec, Jolanta Kucharska-Mazur, Ryszard Kaminski, Michael Smolka, Hans Rommelschpacher, Catrin Wernicke, Agnieszka Tymicz & Lutz Gerhardt Schmidt (August 2002). "Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence". Psychiatry Research. 111 (2–3): 229–33. doi:10.1016/S0165-1781(02)00145-2. PMID 12374639. S2CID 6493515.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ San-Yuan Huang, Ru-Band Lu, Kuo-Hsing Ma, Mee-Jen Shy & Wei-Wen Lin (January 2008). "Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups". Drug and Alcohol Dependence. 92 (1–3): 20–26. doi:10.1016/j.drugalcdep.2007.06.003. PMID 17630229.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Soo-Churl Cho, Jae-Won Kim, Boong-Nyun Kim, Jun-Won Hwang, Mira Park, Soon Ae Kim, Dae-Yeon Cho, Hee-Jeong Yoo, Un-Sun Chung, Jung-Woo Son & Tae-Won Park (2008). "No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample". Neuropsychobiology. 57 (3): 131–138. doi:10.1159/000138916. PMID 18552510. S2CID 7062834.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Piotr Ksiazek, Kinga Buraczynska & Monika Buraczynska (2006). "Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes". Kidney and Blood Pressure Research. 29 (6): 338–43. doi:10.1159/000097356. PMID 17124432. S2CID 25727749.
- ^ Peter Zill, Rolf Engel, Thomas C. Baghai, Georg Juckel, Thomas Frodl, Florian Muller-Siecheneder, Peter Zwanzger, Cornelius Schule, Christo Minov, Stefanie Behrens, Rainer Rupprecht, Ulrich Hegerl, Hans Jurgen Moller & Brigitta Bondy (April 2002). "Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression". Neuropsychopharmacology. 26 (4): 489–93. doi:10.1016/S0893-133X(01)00386-4. PMID 11927173.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Kazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Hitoshi Takahashi, Tetsuo Shimizu & Toshio Suzuki (October 2007). "No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population". Biological & Pharmaceutical Bulletin. 30 (10): 1996–1998. doi:10.1248/bpb.30.1996. PMID 17917281.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ P. G. Sand, T. Mori, C. Godau, G. Stober, P. Flachenecker, P. Franke, M. M. Nothen, J. Fritze, W. Maier, K.-P. Lesch, P. Riederer, H. Beckmann & J. Deckert (November 2002). "Norepinephrine transporter gene (NET) variants in patients with panic disorder". Neuroscience Letters. 333 (1): 41–44. doi:10.1016/S0304-3940(02)00984-9. PMID 12401556. S2CID 19657809.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Christopher A. Rippel, Andrew J. Kobets, Dustin Y. Yoon, Phillip N. Williams, Yin Yao Shugart, Dana D. Bridges, David J. Vandenbergh & Harvey S. Singer (October 2006). "Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association". Psychiatric Genetics. 16 (5): 179–80. doi:10.1097/01.ypg.0000218622.96127.71. PMID 16969268.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ J. Samochowiec, F. Rybakowski, P. Czerski, M. Zakrzewska, G. Stepien, J. Pelka-Wysiecka, J. Horodnicki, J. K. Rybakowski & J. Hauser (2001). "Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers". Neuropsychobiology. 43 (4): 248–53. doi:10.1159/000054898. PMID 11340364. S2CID 24521817.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
Further reading
[edit]- E. G. Jonsson, M. M. Nothen, J. P. Gustavsson, H. Neidt, R. Bunzel, P. Propping & G. C. Sedvall (June 1998). "Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers". Psychiatry Research. 79 (1): 1–9. doi:10.1016/S0165-1781(98)00027-4. PMID 9676821. S2CID 40355623.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - GeneCards